GS vs TMO: Which Is the Better Buy?
Side-by-side comparison of The Goldman Sachs Group, Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
The Goldman Sachs Group, Inc. · Financial Services
$926.55
-98.0% upside to fair value
Grade D
VS
Thermo Fisher Scientific Inc. · Healthcare
$462.60
+10.1% upside to fair value
Grade B
QuantHub Verdict
TMO has more upside to fair value
(+10.1%).
GS trades at a lower forward P/E
(15.6x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
GS |
TMO |
| Current Price |
$926.55 |
$462.60 |
| Fair Value Estimate |
$18.16 |
$509.20 |
| Upside to Fair Value |
-98.0%
|
+10.1%
|
| Market Cap |
$275.0B |
$171.9B |
| Forward P/E |
15.6x
|
25.1x
|
| EV / EBITDA |
30.6x
|
19.0x
|
| Price / Sales |
2.5x
|
3.8x
|
| Price / FCF |
-5.8x
|
25.5x
|
| Revenue Growth YoY |
-45.4%
|
+6.2%
|
| Gross Margin |
55.5%
|
39.4%
|
| Operating Margin |
20.5%
|
17.8%
|
| Return on Equity |
14.6%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
—
|
3.92%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
The Goldman Sachs Group, Inc. operates as a leading global financial services firm specializing in investment banking, securities, investment management, and consumer banking. The company benefits from a high-quality business model characterized by strong brand recognition, deep client relationships, and a history of stable leadership. However, the stock is currently significantly overvalued, tra…
Thermo Fisher Scientific Inc. operates in the healthcare sector, specializing in medical diagnostics and research tools across four main segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company demonstrates medium business quality with steady revenue growth of 6.2% and earnings growth of 9.6% in the most recent q…
Accumulation Zones
| Metric |
GS |
TMO |
| Zone Low |
$13.62 |
$381.90 |
| Zone High |
$15.44 |
$432.82 |
| In Buy Zone? |
No
|
No
|